Cognetivity Neurosciences Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CGNSF has 93.56 million shares outstanding.
| Current Share Class | 93.56M |
| Shares Outstanding | 93.56M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.48% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.97% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.35 |
| Interest Coverage | -0.94 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -96.20% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 61.91% |
| Weighted Average Cost of Capital (WACC) | 262.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.97% in the last 52 weeks. The beta is 0.86, so CGNSF's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -99.97% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 40.80 |
| Average Volume (20 Days) | 26,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, CGNSF had revenue of 71,260 and -6.22 million in losses. Loss per share was -0.07.
| Revenue | 71,260 |
| Gross Profit | -911,205 |
| Operating Income | -3.07M |
| Pretax Income | -6.22M |
| Net Income | -6.22M |
| EBITDA | -3.05M |
| EBIT | -3.07M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 11,930 in cash and 985,036 in debt, with a net cash position of -973,106 or -0.01 per share.
| Cash & Cash Equivalents | 11,930 |
| Total Debt | 985,036 |
| Net Cash | -973,106 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -4.95M |
| Book Value Per Share | -0.12 |
| Working Capital | -5.08M |
Cash Flow
In the last 12 months, operating cash flow was -2.78 million and capital expenditures -120, giving a free cash flow of -2.78 million.
| Operating Cash Flow | -2.78M |
| Capital Expenditures | -120 |
| Free Cash Flow | -2.78M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,302.86% |
| Pretax Margin | -8,732.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CGNSF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.71% |
| Shareholder Yield | -19.71% |
| Earnings Yield | -6,620,142.55% |
| FCF Yield | -2,952,811.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CGNSF has an Altman Z-Score of -152.15 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -152.15 |
| Piotroski F-Score | 1 |